H.C. Wainwright analyst Yi Chen instituted a $15 price target on shares of HTG Molecular following the reverse stock split. The analyst keeps a Buy rating on the shares. Chen believes HTG’s EdgeSeq technology makes RNA profiling scalable, "thus allowing expedited wet-lab processing and data analysis and enabling efficient screening of compounds."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HTGM:
- HTG Molecular provides highlights of second event in KOL webcast series
- HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series
- HTG Molecular Diagnostics Blasts Up after Public Offering Close
- HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering
- HTG Molecular prices shares and warrants offering at combined price of $7.75
